870289-60-4

Basic information

• Product Name: Pyrimidine, 4,6-bis(4-methoxyphenyl)-2-methyl-
• CAS NO: 870289-60-4
• Molecular Formula: C19H18N2O2
• Molecular Weight: 306.364
• Mol File: 870289-60-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Pyrimidine, 4,6-bis(4-methoxyphenyl)-2-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyrimidine, 4,6-bis(4-methoxyphenyl)-2-methyl-(870289-60-4)
• EPA Substance Registry System: Pyrimidine, 4,6-bis(4-methoxyphenyl)-2-methyl-(870289-60-4)

Safety Data

• Hazardous Substances Data: 870289-60-4(Hazardous Substances Data)

Upstream product

• 124-42-5 acetamidine hydrochloride 
• 123-11-5 4-methoxy-benzaldehyde 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 5720-07-0 4-methoxyphenylboronic acid 
• 1780-26-3 2,4-dichloro-2-methylpyrimidine 
• 1194-22-5 2-methyl-4,6-dihydroxypyrimidine 

Downstream Products

• 870289-62-6 {4-[4,6-bis(4-methoxyphenyl)pyrimidin-2-ylmethoxy]-2-methylphenoxy}acetic acid methyl ester 
• 870289-61-5 2-bromomethyl-4,6-bis(4-methoxyphenyl)pyrimidine 

Relevant articles and documents

Synthesis of 4-aryl and unsymmetrical 4,6-diarylpyrimidines by the Suzuki-Miyaura cross-coupling reaction

A two-step procedure for the synthesis of 4-arylpyrimidines from inexpensive 4,6-dichloropyrimidine via a Suzuki-Miyaura/hydrodechlorination reaction sequence is described. The reaction resulted in the predominant formation of mono-arylated product. The c

An efficient and convenient multicomponent reaction for the synthesis of 2-methyl-4,6-diarylpyrimidine under solvent-free conditions

(Chemical Equation Presented) An efficient and convenient method for the preparation of 2-methyl-4,6-diarylpyrimidine derivatives by the multicomponent reactions of aromatic aldehydes, aromatic ketones, and acetamidine hydrochloride in the presence of sod

COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPARδ .